Trial Profile
PHASE II STUDY OF MONOCLONAL ANTIBODY 17-1A WITH GM-CSF IN TREATMENT OF 5-FU RESISTANT COLORECTAL CANCER
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Edrecolomab (Primary) ; Sargramostim (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 18 Jul 2017 New trial record